Vanguard Group Inc Volitionrx LTD Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Volitionrx LTD stock. As of the latest transaction made, Vanguard Group Inc holds 706,060 shares of VNRX stock, worth $353,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares

706,060

Previous 636,667 10.9%

Holding current value

$353,030

Previous $382,000 5.24%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.51 - $0.67 $35,390 - $46,493	69,393 Added 10.9%	706,060 $402,000
Q2 2024 Aug 13, 2024	BUY	$0.59 - $0.91 $295 - $455	500 Added 0.08%	636,667 $388,000
Q1 2024 May 10, 2024	BUY	$0.72 - $1.19 $4,700 - $7,768	6,528 Added 1.04%	636,167 $483,000
Q4 2023 Feb 14, 2024	BUY	$0.55 - $0.88 $47,957 - $76,731	87,195 Added 16.07%	629,639 $453,000
Q3 2023 Nov 14, 2023	BUY	$0.69 - $1.53 $15,211 - $33,730	22,046 Added 4.24%	542,444 $374,000
Q2 2023 Aug 14, 2023	BUY	$1.39 - $2.02 $20,016 - $29,088	14,400 Added 2.85%	520,398 $723,000
Q1 2023 May 15, 2023	BUY	$1.54 - $2.68 $3,087 - $5,373	2,005 Added 0.4%	505,998 $966,000
Q4 2022 Feb 10, 2023	BUY	$1.39 - $2.6 $1,004 - $1,879	723 Added 0.14%	503,993 $1.22 Million
Q1 2022 May 13, 2022	SELL	$2.41 - $3.24 $15,183 - $20,412	-6,300 Reduced 1.24%	503,270 $1.52 Million
Q4 2021 Feb 14, 2022	SELL	$3.02 - $4.13 $6,607 - $9,036	-2,188 Reduced 0.43%	509,570 $1.6 Million
Q3 2021 Nov 12, 2021	BUY	$2.98 - $3.48 $37,765 - $44,102	12,673 Added 2.54%	511,758 $1.59 Million
Q2 2021 Aug 13, 2021	BUY	$3.01 - $3.78 $1.5 Million - $1.89 Million	499,085 New	499,085 $1.64 Million

Others Institutions Holding VNRX

# of Institutions

Shares Held

21.2M

Call Options Held

Put Options Held

View Full List

About VOLITIONRX LTD

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $28.6M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

More about VNRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Volitionrx LTD Transaction History